Renhe Pharmacy Co.,Ltd (SHE:000650)
China · Delayed Price · Currency is CNY 5.92
+0.08 (1.37%)
Feb 3, 2026, 3:04 PM CST
Renhe Pharmacy Co.,Ltd Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 445.37 | 481.91 | 567.26 | 574.43 | 665.02 | 580.18 |
Depreciation & Amortization | 121.82 | 121.82 | 141.7 | 117.15 | 86.64 | 82.2 |
Other Amortization | 3.68 | 3.68 | 5.45 | 6.58 | 5.5 | 4.2 |
Loss (Gain) From Sale of Assets | -1.37 | -1.37 | 0.27 | -0.34 | -16.84 | -0.02 |
Asset Writedown & Restructuring Costs | 105.01 | 105.01 | 207.63 | 32.42 | 1.44 | 0.31 |
Loss (Gain) From Sale of Investments | -88.74 | -88.74 | -76.09 | -68.43 | -31.45 | -71.33 |
Provision & Write-off of Bad Debts | 28.61 | 28.61 | 3.92 | 6.67 | 2.42 | 1.56 |
Other Operating Activities | 671.88 | 93.21 | 80.17 | 173.97 | 140.89 | 98.09 |
Change in Accounts Receivable | 149.68 | 149.68 | -118.15 | 127.1 | -62.47 | 54.15 |
Change in Inventory | 7.71 | 7.71 | 9.78 | 111.63 | -124.42 | 66.95 |
Change in Accounts Payable | -353.64 | -353.64 | -313.28 | 182.28 | 101.35 | 68.87 |
Change in Other Net Operating Assets | 15.53 | 15.53 | - | 17.32 | 10.39 | 0.54 |
Operating Cash Flow | 1,099 | 557.26 | 499.47 | 1,270 | 777.72 | 886.79 |
Operating Cash Flow Growth | 87.30% | 11.57% | -60.67% | 63.30% | -12.30% | 27.79% |
Capital Expenditures | -104.2 | -285.72 | -186.55 | -221.09 | -499.78 | -221.1 |
Sale of Property, Plant & Equipment | 0.6 | 8.95 | 2.02 | 0.29 | 22.63 | 1.14 |
Cash Acquisitions | -0.1 | - | - | - | -704.65 | - |
Divestitures | - | - | - | 15.78 | - | 188.82 |
Investment in Securities | -145.56 | -268.3 | -187.49 | -413.66 | 1,472 | -1,236 |
Other Investing Activities | 106.11 | 82.63 | 77.97 | 43.52 | 28.93 | 64.43 |
Investing Cash Flow | -143.14 | -462.44 | -294.04 | -575.17 | 319.26 | -1,203 |
Short-Term Debt Issued | - | - | - | - | - | 60 |
Total Debt Issued | - | - | - | - | - | 60 |
Short-Term Debt Repaid | - | - | - | - | -60 | - |
Long-Term Debt Repaid | - | -5.89 | -7.07 | -5.55 | -3.55 | - |
Total Debt Repaid | -5.89 | -5.89 | -7.07 | -5.55 | -63.55 | - |
Net Debt Issued (Repaid) | -5.89 | -5.89 | -7.07 | -5.55 | -63.55 | 60 |
Issuance of Common Stock | - | - | - | - | 139.75 | 833.85 |
Repurchase of Common Stock | -39.93 | -39.93 | -60.08 | - | -199.64 | - |
Common Dividends Paid | -210.31 | -279.93 | -279.42 | -140.17 | -283.22 | - |
Other Financing Activities | -90.89 | -58.03 | -69.49 | -84.36 | -55.53 | -276 |
Financing Cash Flow | -347.03 | -383.78 | -416.06 | -230.08 | -462.19 | 617.85 |
Foreign Exchange Rate Adjustments | - | - | - | -0 | -0 | - |
Net Cash Flow | 609.21 | -288.96 | -210.63 | 464.74 | 634.79 | 301.76 |
Free Cash Flow | 995.18 | 271.54 | 312.92 | 1,049 | 277.93 | 665.69 |
Free Cash Flow Growth | 232.26% | -13.22% | -70.17% | 277.39% | -58.25% | 21.06% |
Free Cash Flow Margin | 26.48% | 6.66% | 6.22% | 20.35% | 5.63% | 15.56% |
Free Cash Flow Per Share | 0.71 | 0.20 | 0.22 | 0.75 | 0.20 | 0.53 |
Cash Income Tax Paid | 395 | 642.78 | 640.21 | 520.63 | 359.93 | 494.23 |
Levered Free Cash Flow | 815.84 | 125.8 | 136.97 | 892.17 | 211.09 | 485.17 |
Unlevered Free Cash Flow | 815.92 | 125.9 | 137.18 | 892.43 | 211.7 | 486.06 |
Change in Working Capital | -186.88 | -186.88 | -430.84 | 427.52 | -75.91 | 191.6 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.